Healthcare provider profile · identity verified

Meagan Weaver, CNP

Nurse Practitioner · COLUMBUS, OH · NPI 1457632408

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	370	124
Amlodipine Besylate	Amlodipine Besylate	289	107
Albuterol Sulfate Hfa	Albuterol Sulfate	239	100
Losartan Potassium	Losartan Potassium	219	74
Gabapentin	Gabapentin	208	78
Prednisone	Prednisone	191	119
Lisinopril	Lisinopril	165	58
Hydrochlorothiazide	Hydrochlorothiazide	158	56
Omeprazole	Omeprazole	151	55
Trazodone Hcl	Trazodone Hcl	134	43
Rosuvastatin Calcium	Rosuvastatin Calcium	133	41
Fluticasone Propionate	Fluticasone Propionate	130	55
Metoprolol Succinate	Metoprolol Succinate	128	54
Levothyroxine Sodium	Levothyroxine Sodium	113	42
Tizanidine Hcl	Tizanidine Hcl	109	49
Metformin Hcl	Metformin Hcl	104	33
Tramadol Hcl	Tramadol Hcl	104	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	97	32
Diclofenac Sodium	Diclofenac Sodium	94	54
Pantoprazole Sodium	Pantoprazole Sodium	90	36
Carvedilol	Carvedilol	83	24
Duloxetine Hcl	Duloxetine Hcl	82	23
Metoprolol Tartrate	Metoprolol Tartrate	82	29
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	79	37
Alendronate Sodium	Alendronate Sodium	77	30
Azithromycin	Azithromycin	77	53
Sertraline Hcl	Sertraline Hcl	77	22
Pravastatin Sodium	Pravastatin Sodium	76	23
Oxybutynin Chloride Er	Oxybutynin Chloride	73	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	22
Tamsulosin Hcl	Tamsulosin Hcl	71	22
Eliquis	Apixaban	70	23
Ozempic	Semaglutide	69	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	66	13
Famotidine	Famotidine	61	30
Ibuprofen	Ibuprofen	61	25
Potassium Chloride	Potassium Chloride	61	22
Buspirone Hcl	Buspirone Hcl	58	18
Clopidogrel	Clopidogrel Bisulfate	58	17
Furosemide	Furosemide	58	29
Glipizide	Glipizide	56	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	17
Meloxicam	Meloxicam	48	24
Simvastatin	Simvastatin	48	17
Escitalopram Oxalate	Escitalopram Oxalate	47	15
Hydroxyzine Hcl	Hydroxyzine Hcl	44	22
Montelukast Sodium	Montelukast Sodium	43	15
Triamcinolone Acetonide	Triamcinolone Acetonide	43	29
Fluoxetine Hcl	Fluoxetine Hcl	42	20
Bupropion Xl	Bupropion Hcl	41	12
Allopurinol	Allopurinol	40	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	17
Glimepiride	Glimepiride	40	12
Pioglitazone Hcl	Pioglitazone Hcl	40	suppressed
Trulicity	Dulaglutide	38	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	26
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Mirtazapine	Mirtazapine	35	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	16
Pregabalin	Pregabalin	34	suppressed
Spironolactone	Spironolactone	33	suppressed
Baclofen	Baclofen	32	suppressed
Ezetimibe	Ezetimibe	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	17
Clonazepam	Clonazepam	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Meclizine Hcl	Meclizine Hcl	29	13
Ondansetron Odt	Ondansetron	28	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Clotrimazole	Clotrimazole	27	11
Donepezil Hcl	Donepezil Hcl	27	15
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Finasteride	Finasteride	25	suppressed
Naproxen	Naproxen	25	12
Nifedipine Er	Nifedipine	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	13
Cephalexin	Cephalexin	23	21
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Lidocaine	Lidocaine	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	16
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Ammonium Lactate	Ammonium Lactate	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Fluconazole	Fluconazole	18	15
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Methimazole	Methimazole	17	suppressed
Methylprednisolone	Methylprednisolone	17	14
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Hydrocortisone	Hydrocortisone	16	11
Linzess	Linaclotide	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Cilostazol	Cilostazol	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Glyburide	Glyburide	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error